November 2025: Transforming Cancer Care with Wearables

Wearable implant delivering continuous, personalized cancer therapy for everyday life.

Image credits: OptoBio

We are excited to introduce the SOMA system from OptoBio, a next-generation wearable and implantable solution designed to transform the way we treat cancer. Sleek, discreet, and built for everyday life, SOMA merges minimally-invasive implant technology with a wearable over-ear module, offering continuous, bioelectronic therapy without interrupting your routine.

Unlike treatments that tie you to hospital stays or scheduled infusions, SOMA brings targeted care directly into your daily life. With a discreet implant the size of a shirt button, ultrathin bio-threads, and an over-ear wearable that powers and monitors the system, you can receive precision therapy while remaining present in the moment.

Seamlessly integrated with the SOMA app and clinician interface, the system enables real-time data sharing, personalized adjustments, and continuous monitoring. Whether at home, at work, or on the go, it provides freedom, style, and advanced therapy without compromise.

About SOMA

Created to enhance human wellbeing through wearable and implantable healthcare technology, the SOMA system fuses design and intelligence into one seamless experience. By bringing advanced neuro-electronic and bioanalytic features into everyday therapy, OptoBio redefine how we treat, monitor, and live with cancer.

Sam Draper
November 4, 2025

November 2025

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

MemoMind Begins Accepting Orders of Its First AI Glasses

The most feature-complete model in the MemoMind lineup.

Everbridge Partners with RiskBand to Deliver World-Class Workplace Security

Almost on a weekly basis, there are reports of an active shooter in the workplace...

Foxconn Partners With tBPC and ITRI to Advance Telemedicine

Foxconn Technology Group has announced its expansion into the Southeast Asian medical device market.

Kaia Health Partners With Chiesi Group to Commercialize Kaia COPD Rehabilitation App in Europe

Digital therapeutics company Kaia Health is partnering with Italian pharma firm Chiesi Group to...
Discover more